+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of flecainide in patients with resistant ventricular tachycardia and congestive heart failure



Effect of flecainide in patients with resistant ventricular tachycardia and congestive heart failure



Japanese Circulation Journal 52(8): 800




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028167352

Download citation: RISBibTeXText


Related references

Prognostic value of frequent episodes of Non-Sustained Ventricular Tachycardia in patients with Congestive Heart Failure The Italian Network Congestive Heart Failure database. Journal of the American College of Cardiology 33(2 Suppl. A): 190A-191A, 1999

Is non-sustained ventricular tachycardia an independent predictor of 1 year mortality also in patients with mild and moderate congestive heart failure? The Italian Network Congestive Heart Failure database. European Heart Journal 19(ABST Suppl. ): 513, 1998

Flecainide half-life prolongation in 2 patients with congestive heart failure and complex ventricular arrhythmias. Clinical Pharmacokinetics 14(3): 187-188, 1988

Management of Asymptomatic Nonsustained Ventricular Tachycardia in Patients with Congestive Heart Failure. Cardiology in Review 2(2): 58-66, 1994

Nonsustained ventricular tachycardia and sudden death in patients with severe congestive heart failure. Clinical Research 36(3): 322A, 1988

Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation 87(6 Suppl. 6): VI49-VI55, 1993

Prognostic importance of the length of ventricular tachycardia in patients with nonischemic congestive heart failure. American Heart Journal 130(3 Part 1): 489-493, 1995

Evaluation of proarrhythmic effect of antiarrhythmic drugs on ventricular tachycardia associated with congestive heart failure. Japanese Circulation Journal 56(1): 69-76, 1992

Effect of ventricular tachycardia at baseline on response to vasodilator therapy in congestive heart failure. Circulation 86(4 Suppl. 1): I586, 1992

Exploration of the minimal dose of amiodarone to suppress ventricular tachycardia in patients with congestive heart failure. Circulation 86(4 Suppl. 1): I809, 1992

Relationship between ejection fraction and ventricular tachycardia events in patients with congestive heart failure on vasodilator therapy. Circulation 86(4 Suppl. 1): I395, 1992

Cardiac and skeletal muscle abnormalities in cardiomyopathy comparison of patients with ventricular tachycardia or congestive heart failure. Journal of the American College of Cardiology 10(3): 608-618, 1987

The effect of sotalol on inducible sustained ventricular tachycardia relationship to ejection fraction and congestive heart failure. Circulation 84(4 Suppl. 2): II349, 1991

Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Circulation 87(6 Suppl): Vi49-Vi55, 1993

Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines. American Journal of Cardiology 68(11): 1194-1202, 1991